The Florida Board of Pharmacy has proposed an amendment of Rule 64B16-27.797 (The Standards of Practice for Compounding Sterile Products) to update the standards to comply with the United States Pharmacopeia (USP) compounding chapters and all applicable state and federal regulations, including compliance with current Good Manufacturing Practices (GMPs) for pharmacies registered as 503B outsourcing facilities.
While the comment period has closed, it's important to stay engaged with these developments in the industry. Seeking a convenient way to stay informed about regulatory updates in the drug supply chain landscape? Subscribe now to REAL Solutions Group's monthly HealthRISC Report and receive a comprehensive report on the most recent regulatory changes, delivered directly to your inbox at the beginning of each month. Gain valuable insights - such as the most recent changes to Florida's rules on sterile compounding - to stay ahead in the industry.